ResMed | RMD - Betriebsaufwand

Aktienkurs
219.85
Täglich Wechseln
0.34 0.15%
Monatlich
-2.85%
Jährlich
-6.80%
Q2 Prognose
215.15




Betriebsaufwand Veränderung Datum
Ansell USD 880.1M 465.65M 2025-12
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
CSL USD 5.7B 2.82B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Fisher Paykel Healthcare NZD 802.4M 24.1M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Idexx Laboratories USD 774.97M 24.58M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Philips EUR 4.38B 405M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 925.21M 51.98M 2025-12
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.22B 28.8M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03